Publication | Closed Access

Xanthohumol exhibits anti-myeloma activity in vitro through inhibition of cell proliferation, induction of apoptosis via the ERK and JNK-dependent mechanism, and suppression of sIL-6R and VEGF production

Hematological MalignancyVegf ProductionMedicineMalignant Blood DisorderImmunologyCell DeathCell ProliferationAnti-cancer AgentRadiation OncologyAnti-myeloma ActivityCell BiologyTumor MicroenvironmentCancer ResearchHealth Sciences